No Data
No Data
Nephron Initiates Icon PLC(ICLR.US) With Buy Rating, Announces Target Price $280
Nephron Upgrades ICON to Buy, Price Target Is $280
Are Investors Undervaluing ICON Public Limited Company (NASDAQ:ICLR) By 48%?
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
Baird Upgrades Icon PLC(ICLR.US) to Buy Rating, Raises Target Price to $242
Icon PLC (ICLR) Down 4.1% Since Last Earnings Report: Can It Rebound?